

LONDON MARKET OPEN: Countryside down as CEO departs; ASOS to leave AIM


(Sharecast News) - Dechra Pharmaceuticals said on Thursday that the full-year outlook was towards the upper end of management expectations as it repor...


(Sharecast News) - Pharmaceutical giant Dechra has acquired the worldwide rights to verdinexor, a novel treatment of all forms and stages of canine ly...


LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing


LONDON MARKET OPEN: Stocks rise; Darktrace surges on bright outlook


Dechra Pharmaceuticals buys worldwide rights to verdinexor drug


LONDON MARKET PRE-OPEN: Games Workshop lifts dividend as revenue rises


(Sharecast News) - Dechra Pharmaceuticals was under the cosh on Tuesday after Exane BNP Paribas initiated coverage of the stock at 'neutral' on valuat...